Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Qi, Lisha ^a,b,c   Sun, Baocun ^a,b,c   Liu, Zhiyong ^a,b,c   Cheng, Runfen ^a,b,c   Li, Yixian ^a   Zhao, Xiulan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b The Key Lab of Tianjin Cancer Prevention and Treatment   (China)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN; VIMENTIN; WNT3A PROTEIN; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; WNT3A PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CELL DIFFERENTIATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; COLON TUMOR; DISEASE COURSE; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; NUDE MOUSE; PATHOLOGY; TIME;

ADULT; ANIMALS; BETA CATENIN; CADHERINS; COLONIC NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HCT116 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE, NUDE; MIDDLE AGED; TIME FACTORS; TRANSFECTION; UP-REGULATION; VIMENTIN; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84965191140     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0107-4     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Sanjoaquin MA, Choodari-Oskooei B, Dolbear C, Putcha V, Sehgal A, Key TJ, Moller H: Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001. Eur J Cancer Prev 2007, 16:10-16.
3. Ding S, Zhang W, Xu Z, Xing C, Xie H, Guo H, Chen K, Song P, Gu Y, Xiao F, Zhou L, Zheng S: Induction of an EMT-like transformation and MET in vitro. J Transl Med 2013, 11:164.
4. Miao CG, Yang YY, He X, Li XF, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J: Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal 2013, 25:2069-2078.
5. Miki T, Yasuda SY, Kahn M: Wnt/beta-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Rev 2011, 7:836-846.
6. de Sousa EM, Vermeulen L, Richel D, Medema JP: Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res 2011, 17:647-653.
7. Pawlikowski JS, McBryan T, van Tuyn J, Drotar ME, Hewitt RN, Maier AB, King A, Blyth K, Wu H, Adams PD: Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci U S A 2013, 110:16009-16014.
8. Yang L, Perez AA, Fujie S, Warden C, Li J, Wang Y, Yung B, Chen YR, Liu X, Zhang H, Zheng S, Liu Z, Ann D, Yen Y: Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer 2014, 14:124.
9. Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L: Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012, 31:2725-2737.
10. Mikels AJ, Nusse R: Wnts as ligands: processing, secretion and reception. Oncogene 2006, 25:7461-7468.
11. Voloshanenko O, Erdmann G, Dubash TD, Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T, Anchang B, Demir K, Boehm C, Leible S, Ball CR, Glimm H, Spang R, Boutros M: Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun 2013, 4:2610.
12. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
13. Widelitz R: Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 2005, 23:111-116.
14. Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T, Liu Y, Xiang R, Li N: SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/beta-catenin signal network. Cancer Lett 2013, 336:379-389.
15. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z: EphA2 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer cells. Oncogene 2014, 33:2737-2747.
16. Blavier L, Lazaryev A, Shi XH, Dorey FJ, Shackleford GM, DeClerck YA: Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT). Cancer Biol Ther 2010, 10:198-208.
17. Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M: Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer 2013, 13:496-506.
18. Kanzawa M, Semba S, Hara S, Itoh T, Yokozaki H: WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells. Pathobiology 2013, 80:235-244.
19. Wu Y, Ginther C, Kim J, Mosher N, Chung S, Slamon D, Vadgama JV: Expression of Wnt3 activates Wnt/beta-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells. Mol Cancer Res 2012, 10:1597-1606.
20. Bao XL, Song H, Chen Z, Tang X: Wnt3a promotes epithelial-mesenchymal transition, migration, and proliferation of lens epithelial cells. Mol Vis 2012, 18:1983-1990.
21. Zhang S, Qi L, Li M, Zhang D, Xu S, Wang N, Sun B: Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer. J Exp Clin Cancer Res 2008, 27:62.
22. Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh ML, Shiras A: Wnt3a mediated activation of Wnt/beta-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci 2013, 54:44-57.
23. Lamb R, Ablett MP, Spence K, Landberg G, Sims AH, Clarke RB: Wnt pathway activity in breast cancer sub-types and stem-like cells. PLoS ONE 2013, 8:e67811.
24. Verras M, Brown J, Li X, Nusse R, Sun Z: Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res 2004, 64:8860-8866.
25. Fox SA, Richards AK, Kusumah I, Perumal V, Bolitho EM, Mutsaers SE, Dharmarajan AM: Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells. Biochem Biophys Res Commun 2013, 440:82-87.
26. Qiang YW, Shaughnessy JD Jr, Yaccoby S: Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth. Blood 2008, 112:374-382.
27. Nygren MK, Dosen G, Hystad ME, Stubberud H, Funderud S, Rian E: Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 2007, 136:400-413.
28. Lee MA, Park JH, Rhyu SY, Oh ST, Kang WK, Kim HN: Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer. BMC Cancer 2014, 14:125-131.
29. Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R, Ralhan R: Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer 2009, 9:325-334.
30. Li J, Zhou BP: Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49-59.
31. Scheel C, Weinberg RA: Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012, 22:396-403.
32. Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, Xie S, Chen C, Hu L, Xu S, Liang T: Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis 2013, 34:962-973.
33. Yoshida GJ, Saya H: Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun 2014, 443:622-627.
34. Clevers H, Nusse R: Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205.
35. Schafer G, Narasimha M, Vogelsang E, Leptin M: Cadherin switching during the formation and differentiation of the Drosophila mesoderm - implications for epithelial-to-mesenchymal transitions. J Cell Sci 2014, 127:1511-1522.
36. Ludwig. K, E. S. Tse, JY. Wang, Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors, BMC Cancer 13 (2013) 221-232.
37. Yoshida GJ, Saya H, Zouboulis CC: Three-dimensional culture of sebaceous gland cells revealing the role of prostaglandin E2-induced activation of canonical Wnt signaling. Biochem Biophys Res Commun 2013, 438:640-646.
38. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, Brisken C: Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notchdependent mechanism. Proc Natl Acad Sci U S A 2006, 103:3799-3804.
39. Van den Bosch MH, Blom AB, van Lent PL, van Beuningen HM, Blaney Davidson EN, van der Kraan PM, van den Berg WB: Canonical Wnt signaling skews TGF-beta signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal 2014, 26:951-958.
40. Despeaux M, Chicanne G, Rouer E, De Toni-Costes F, Bertrand J, Mansat-DeMasV,VergnolleN,EavesC,Payrastre B, Girault JA, Racaud-Sultan C: Focal adhesion kinase splice variants maintain primitive acute myeloid leukemia cells through altered Wnt signaling. Stem Cells 2012, 30:1597-1610.
41. Kim SE, Choi KY: EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. Cell Signal 2007, 19:1554-1564.
42. Nalesso G, Sherwood J, Bertrand J, Pap T, Ramachandran M, De Bari C, Pitzalis C, Dell'accio F: WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J Cell Biol 2011, 193:551-564.
43. Sonderegger S, Haslinger P, Sabri A, Leisser C, Otten JV, Fiala C, Knofler M: Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 2010, 151:211-220.